Cogstate
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Australia · 51-200 Employees
View Company Info for Free
Overview
Headquarters
L 32 367 Collins St, Melbourne, Victoria...Phone Number
+61 396641300Website
www.cogstate.comRevenue
$27.6 MillionStock Symbol
CGSIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
2
2
1
About Cogstate
Founded in 1999, based out of New Haven, Connecticut, Cogstate is a leading cognitive science company focused on optimizing the measurement of cognition to guide better decision-making. Cogstate commercializes rapid, reliable, sensitive and simple computerized cognitive tests for clinical trials, academic research, healthcare and brain injury.Explore more
Cogstate Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cogstate your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Cogstate recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Cogstate
Product Launch: Get notified when Cogstate launches new products
Check out if Cogstate is spiking on competitors!
Check if Cogstate has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Cogstate has new funding data
Cogstate, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Cogstate had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Cogstate as Masked Content
Find 2 more new buyers
Compare Similar Companies to Cogstate
Compare insights from companies similar to Cogstate, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cogstate is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cogstate is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cogstate.
Cogstate financials insights
Gather financial insights about Cogstate, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$2M
Cogstate Tech Stack
A closer look at the technologies used by Cogstate
See more technologies
Most Recent Scoops
Earnings
Cogstate has reported that it benefited from favorable foreign exchange conditions in FY26, with the finance team implementing forward hedging at beneficial rates following the US Liberation Day tariff announcement, and has noted that maintaining the EBITDA margin in FY27 will require some margin improvement, as the company cannot rely on a comparable drop in the Australian dollar for similar hedging benefits.
Forecasting, Business Finance, Finance, Financial Operations, Risk
Earnings
Cogstate has declared its second annual dividend at AUD 0.04 per share, up from AUD 0.02 per share in the prior year, representing a payout ratio of 40% of net profit after tax, within the company's stated target range of 20% to 50%, with the share buyback program remaining open on an opportunistic basis.
Earnings, Finance, Financial Operations
Earnings
Cogstate has reported second-half clinical trials revenue of AUD 32.7 million for fiscal year 2026, up 17% on the prior corresponding period and up 27% versus the first half of FY26, with significant contribution from Central Rating Programs in the second half.
Earnings, Clinical Operations, Finance
Earnings
Cogstate has reported AUD 48.3 million of contracted future revenue expected to be recognized in FY27, up 54% on the prior year, of which AUD 46.1 million relates to clinical trials revenue, up 58% year-over-year, as part of a total contracted future revenue backlog of AUD 118.5 million at fiscal year-end 2026.
Earnings, Clinical Operations, Finance
Person-Based
Earnings, Events, Finance, Investor Relations
Cogstate News & Media
Cogstate Limited (COGZF) Discusses Clinical Trials Growth Through Indication and Solution Expansion With Focus on Psychiatry and Narcolepsy Transcript
Cogstate Limited (COGZF) Discusses Clinical Trials Growth Through Indication and Solution Expansion With Focus on Psychiatry and Narcolepsy June 9, 2026...Is Cogstate Limited's (ASX:CGS) Latest Stock Performance A Reflection Of Its Financial Health?
Most readers would already be aware that Cogstate's (ASX:CGS) stock increased significantly by 51% over the past three...Cogstate Limited (COGZF) FY 2025 Earnings Call Transcript
Cogstate Limited (OTCQX:COGZF) FY 2025 Earnings Conference Call August 21, 2025 7:00 PM ETCompany ParticipantsBradley John O'Connor - CEO, MD &...One Cogstate Insider Raised Their Stake In The Previous Year - Yahoo Finance
From what we can see, insiders were net buyers in Cogstate Limited's ( ASX:CGS ) during the past 12 months. That is...
Read more news
Top Business Services Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Cogstate
Sign Up For FreeTo access detailed company insights
Founded in 1999, based out of New Haven, Connecticut, Cogstate is a leading cognitive science company focused on optimizing the measurement of cognition to guide better decision-making. Cogstate commercializes rapid, reliable, sensitive and simple computerized cognitive tests for clinical trials, academic research, healthcare and brain injury.... Read More
